Self-delivery nanomedicine for chemotherapy sensitized photodynamic therapy

Chem Commun (Camb). 2021 Jul 28;57(59):7296-7299. doi: 10.1039/d1cc02318g. Epub 2021 Jul 5.

Abstract

A chlorine e6 (Ce6) and curcumin (Cur) based self-delivery nanomedicine (CeCu) is prepared for chemotherapy sensitized photodynamic therapy (PDT). The chemotherapeutic agent of Cur could inhibit the TrxR activity to destroy the cellular ROS-defence system for enhanced PDT, which provides synergistic effects for tumor precision therapy in consideration of the unfavorable tumor microenvironments.

MeSH terms

  • Animals
  • Cell Line
  • Cell Survival / drug effects
  • Chlorophyllides
  • Curcumin / chemistry
  • Curcumin / metabolism
  • Curcumin / pharmacology
  • Humans
  • Mice
  • Microscopy, Confocal
  • Nanomedicine*
  • Neoplasms / drug therapy
  • Neoplasms / pathology
  • Photochemotherapy / methods*
  • Photosensitizing Agents / chemistry
  • Photosensitizing Agents / pharmacology
  • Photosensitizing Agents / therapeutic use
  • Porphyrins / chemistry
  • Porphyrins / metabolism
  • Porphyrins / pharmacology
  • Reactive Oxygen Species / metabolism
  • Thioredoxin-Disulfide Reductase / antagonists & inhibitors
  • Thioredoxin-Disulfide Reductase / metabolism
  • Transplantation, Heterologous
  • Tumor Microenvironment

Substances

  • Chlorophyllides
  • Photosensitizing Agents
  • Porphyrins
  • Reactive Oxygen Species
  • phytochlorin
  • Thioredoxin-Disulfide Reductase
  • Curcumin